An ASH That Moves The Ball – And The Ticker Price

The American Society of Hematology meeting showcased breakthroughs and some ho-hum news, resulting in rollercoaster-like crests and troughs for biotech stocks.

Hitting bigger business target

More from Clinical Trials

More from R&D